Correction to: BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia

被引：0
|
作者：
Mengjun Zhong
Rili Gao
Ruocong Zhao
Youxue Huang
Cunte Chen
Kehan Li
Xibao Yu
Dingrui Nie
Zheng Chen
Xin Liu
Zhuandi Liu
Shaohua Chen
Yuhong Lu
Zhi Yu
Liang Wang
Peng Li
Chengwu Zeng
Yangqiu Li
机构：
[1] Jinan University,Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology
[2] Chinese Academy of Sciences,Center for Cell Regeneration and Biotherapy, Guangzhou Institutes of Biomedicine and Health
[3] Jinan University,Department of Hematology, First Affiliated Hospital
[4] Jinan University,Department of Oncology, First Affiliated Hospital
来源：
Cell Death & Disease | / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] BET bromodomain inhibitors antagonize Brd4-Mediator complexes to undermine the acute myeloid leukemia cell state
    Bhagwat, Anand S.
    Roe, Jae-Seok
    Mok, Beverly A.
    Vakoc, Christopher R.
    CANCER RESEARCH, 2016, 76
  • [32] T-cell lymphoblastic leukemia/lymphoma syndrome with eosinophilia and acute myeloid leukemia
    Lamb, LS
    Neuberg, R
    Welsh, J
    Best, R
    Stetler-Stevenson, M
    Sorrell, A
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2005, 65B (01) : 37 - 41
  • [33] Preferential contribution of B7-H1 to PD-1-mediated T-cell regulation by antigen-pulsed DC
    Tanaka, K
    Tsushima, F
    Hashiguchi, M
    Kamimura, Y
    Youngnak, P
    Kanamaru, F
    Omura, K
    Azuma, M
    FASEB JOURNAL, 2004, 18 (05): : A812 - A812
  • [34] Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses
    Remke, Niklas
    Bisht, Savita
    Oberbeck, Sebastian
    Nolting, Jens
    Brossart, Peter
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (01) : 107 - 121
  • [35] Publisher Correction: Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells
    Kankana Bardhan
    Halil-Ibrahim Aksoylar
    Thibault Le Bourgeois
    Laura Strauss
    Jessica D. Weaver
    Bethany Delcuze
    Alain Charest
    Nikolaos Patsoukis
    Vassiliki A. Boussiotis
    Scientific Reports, 10
  • [36] Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses
    Niklas Remke
    Savita Bisht
    Sebastian Oberbeck
    Jens Nolting
    Peter Brossart
    Cancer Immunology, Immunotherapy, 2021, 70 : 107 - 121
  • [37] PD-1 loss and T-cell exhaustion in CTCL tumoral T cells
    Sanchez-Beato, Margarita
    BLOOD, 2021, 138 (14) : 1201 - 1203
  • [38] Coexistence of T-cell lymphoblastic lymphoma and acute myeloid leukemia mimicking acute lymphocytic leukemia
    Liu, Keyu
    Zhou, Fengling
    Fu, Zexian
    Yin, Junping
    Li, Wei
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2018, 61 (03) : 464 - 467
  • [39] Acute myeloid leukemia-induced T-cell suppression can be reversed by inhibition of the MAPK pathway
    Moshofsky, Kaycee B.
    Cho, Hyun J.
    Wu, Guanming
    Romine, Kyle A.
    Newman, Matthew T.
    Kosaka, Yoko
    McWeeney, Shannon K.
    Lind, Evan F.
    BLOOD ADVANCES, 2019, 3 (20) : 3038 - 3051
  • [40] A NEW FUSION RECEPTOR OVERCOMES PD-1-MEDIATED IMMUNOSUPPRESSION IN ADOPTIVE T CELL THERAPY
    Sebastian, Kobold
    Simon, Grassmann
    Michael, Chaloupka
    Christopher, Lampert
    Fabian, Kraus
    Simon, Rothenfusser
    Max, Schnurr
    Stefan, Endres
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S9 - +
12345